Constellation Brands has acquired a minority stake in Hiyo, enhancing its non-alcoholic beverage portfolio to cater to the growing consumer preference for healthier drinking options.
Target Information
Constellation Brands, Inc. (NYSE: STZ), a prominent player in the beverage alcohol industry, has taken a significant step by acquiring a minority stake in Hiyo, a brand known for its organic, non-alcoholic social tonic. Hiyo is specifically crafted with a proprietary blend of adaptogens, nootropics, and botanicals, designed to cater to consumers' evolving tastes for moderation and flavorful alternatives. Each Hiyo can contains ingredients such as ashwagandha, L-theanine, lion’s mane, lemon balm, passion flower, and ginger, delivering a refreshing beverage that is both low in calories and has 0% alcohol by volume (ABV).
With an emphasis on providing diverse options, Hiyo currently offers four enticing flavors: Blackberry Lemon, Peach Mango, Strawberry Guava, and Watermelon Lime. The brand has already made an impressive mark in the non-alcoholic drinks segment, with over 93% of its consumers also purchasing alcoholic beverages, thereby enhancing participation in traditional drinking occasions. This strategic positioning aligns well with Constellation’s existing portfolio of products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The beverage alcohol industry in the United States has been experiencing a significant transformation over the past few years, with growing interest in healthier and non-alcoholic options. According to industry data, the market for non-alco
Similar Deals
Nielsen IQ → Label Insight
2023
Sojitz Corporation → Sushi Avenue, Inc.
2023
Rabo Investments Corporate Venturing → TRACT
2023
Perfetti Van Melle Group B.V. → Mondelēz International’s gum business
2023
Constellation Brands, Inc.
invested in
Hiyo
in 2025
in a Corporate VC deal